The obesity and cancer link (English)
- New search for: Bifulco, M.
- New search for: Bifulco, M.
In:
ANNALS OF ONCOLOGY
;
26
, 2
;
440-441
;
2015
-
ISSN:
- Article (Journal) / Print
-
Title:The obesity and cancer link
-
Contributors:Bifulco, M. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 26, 2 ; 440-441
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2015-01-01
-
Size:2 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 26, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 259
-
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Salgado, R. / Denkert, C. / Demaria, S. / Sirtaine, N. / Klauschen, F. / Pruneri, G. / Wienert, S. / Van den Eynden, G. / Baehner, F. L. / Penault-Llorca, F. et al. | 2015
- 272
-
Cardiorespiratory fitness as predictor of cancer mortality: a systematic review and meta-analysisSchmid, D. / Leitzmann, M. F. et al. | 2015
- 278
-
Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literatureCardenal, F. / Nadal, E. / Jové, M. / Faivre-Finn, C. et al. | 2015
- 288
-
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†Decoster, L. / Van Puyvelde, K. / Mohile, S. / Wedding, U. / Basso, U. / Colloca, G. / Rostoft, S. / Overcash, J. / Wildiers, H. / Steer, C. et al. | 2015
- 300
-
Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paperCasali, P. G. / Bruzzi, P. / Bogaerts, J. / Blay, J. Y. et al. | 2015
- 307
-
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyMontagna, E. / Bagnardi, V. / Viale, G. / Rotmensz, N. / Sporchia, A. / Cancello, G. / Balduzzi, A. / Galimberti, V. / Veronesi, P. / Luini, A. et al. | 2015
- 313
-
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12Gnant, M. / Mlineritsch, B. / Stoeger, H. / Luschin-Ebengreuth, G. / Knauer, M. / Moik, M. / Jakesz, R. / Seifert, M. / Taucher, S. / Bjelic-Radisic, V. et al. | 2015
- 320
-
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH studyJackisch, C. / Kim, S. B. / Semiglazov, V. / Melichar, B. / Pivot, X. / Hillenbach, C. / Stroyakovskiy, D. / Lum, B. L. / Elliott, R. / Weber, H. A. et al. | 2015
- 325
-
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 studyBonnefoi, H. / Jacot, W. / Saghatchian, M. / Moldovan, C. / Venat-Bouvet, L. / Zaman, K. / Matos, E. / Petit, T. / Bodmer, A. / Quenel-Tueux, N. et al. | 2015
- 332
-
Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancerSunakawa, Y. / Stremitzer, S. / Cao, S. / Zhang, W. / Yang, D. / Wakatsuki, T. / Ning, Y. / Yamauchi, S. / Stintzing, S. / Sebio, A. et al. | 2015
- 340
-
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trialHebbar, M. / Chibaudel, B. / André, T. / Mineur, L. / Smith, D. / Louvet, C. / Dutel, J. L. / Ychou, M. / Legoux, J. L. / Mabro, M. et al. | 2015
- 368
-
Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal eventsSmith, M. R. / Coleman, R. E. / Klotz, L. / Pittman, K. / Milecki, P. / Ng, S. / Chi, K. N. / Balakumaran, A. / Wei, R. / Wang, H. et al. | 2015
- 374
-
Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapyVidal, A. D. / Thalmann, G. N. / Karamitopoulou-Diamantis, E. / Fey, M. F. / Studer, U. E. et al. | 2015
- 407
-
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment†Whelan, J. S. / Bielack, S. S. / Marina, N. / Smeland, S. / Jovic, G. / Hook, J. M. / Krailo, M. / Anninga, J. / Butterfass-Bahloul, T. / Böhling, T. et al. | 2015
- 415
-
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trialMenzies, A. M. / Ashworth, M. T. / Swann, S. / Kefford, R. F. / Flaherty, K. / Weber, J. / Infante, J. R. / Kim, K. B. / Gonzalez, R. / Hamid, O. et al. | 2015
- 422
-
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trialsDoussau, A. / Thiébaut, R. / Geoerger, B. / Schöffski, P. / Floquet, A. / Le Deley, M. C. / Mathoulin-Pélissier, S. / Rizzo, E. / Fumoleau, P. / Le Tourneau, C. et al. | 2015
- 428
-
Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosisBarrera, L. / Montes-Servín, E. / Barrera, A. / Ramírez-Tirado, L. A. / Salinas-Parra, F. / Bañales-Méndez, J. L. / Sandoval-Ríos, M. / Arrieta, . et al. | 2015
- 436
-
T-DM1-related telangiectasias: a potential role in secondary bleeding eventsSibaud, V. / Vigarios, E. / Combemale, P. / Lamant, L. / Lacouture, M. E. / Lacaze, J. L. / Dalenc, F. / Delord, J. P. et al. | 2015
- 437
-
Withdrawal of hormone replacement therapy might affect multigene signature results in early luminal breast cancerNeven, P. / Jongen, L. / Van Asten, K. / Berteloot, P. / Floris, G. / Wildiers, H. et al. | 2015
- 439
-
Can obesity be an advantage for febrile neutropenia?Alkan, A. / Bir, K. / Utkan, G. et al. | 2015
- 440
-
The obesity and cancer linkBifulco, M. et al. | 2015
- 441
-
The harms of low-dose aspirin prophylaxis are overstatedElwood, P. / Morgan, G. et al. | 2015
- 442
-
Reply to the letter to the editor ‘The harms of low-dose aspirin prophylaxis are overstated’ by P. Elwood and G. MorganThorat, M. A. / Cuzick, J. et al. | 2015
- 443
-
Albumin to globulin ratio, a predictor or a misleader?Alkan, A. / Köksoy, E. B. / Utkan, G. et al. | 2015
- 445
-
Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumorsSoria, J. C. / DeBraud, F. / Bahleda, R. / Adamo, B. / Andre, F. / Dienstmann, R. / Delmonte, A. / Cereda, R. / Isaacson, J. / Litten, J. et al. | 2015
- 445
-
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features| 2015